Cubist Systematic Strategies, LLC Procept Bio Robotics Corp Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.38 - $50.75 $3.9 Million - $4.9 Million	96,634 Added 1406.61%	103,504 $5.12 Million
Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $170,994 - $298,226	6,870 New	6,870 $287,000
Q1 2023 May 15, 2023	BUY	$26.64 - $39.74 $652,333 - $973,113	24,487 Added 274.98%	33,392 $948,000
Q4 2022 Feb 14, 2023	SELL	$38.78 - $46.78 $969,306 - $1.17 Million	-24,995 Reduced 73.73%	8,905 $369,000
Q3 2022 Nov 14, 2022	SELL	$30.9 - $50.65 $362,487 - $594,175	-11,731 Reduced 25.71%	33,900 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$29.23 - $44.45 $609,270 - $926,515	20,844 Added 84.09%	45,631 $1.49 Million
Q1 2022 May 16, 2022	BUY	$16.89 - $35.74 $142,298 - $301,109	8,425 Added 51.49%	24,787 $867,000
Q4 2021 Feb 14, 2022	BUY	$24.6 - $46.29 $377,437 - $710,227	15,343 Added 1505.69%	16,362 $409,000
Q3 2021 Nov 15, 2021	BUY	$35.91 - $41.94 $36,592 - $42,736	1,019 New	1,019 $39,000

277

39.5M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.1B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.